Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy
Condition: Breast Cancer Intervention: Drug: Capecitabine Sponsor: Zhejiang Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research | Xeloda